GRI Bio, Inc.GRIEarnings & Financial Report
Nasdaq
NextMar 13, 2026
GRI Q1 2023 Key Financial Metrics
Revenue
$16.0K
Gross Profit
N/A
Operating Profit
$-2.3M
Net Profit
$-2.4M
Gross Margin
N/A
Operating Margin
-14681.3%
Net Margin
-14975.0%
YoY Growth
N/A
EPS
$-5.33
Financial Flow
GRI Bio, Inc. Q1 2023 Financial Summary
GRI Bio, Inc. reported revenue of $16.0K for Q1 2023, with a net profit of $-2.4M (-14975.0% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $16.0K |
|---|---|
| Net Profit | $-2.4M |
| Gross Margin | N/A |
| Operating Margin | -14681.3% |
| Report Period | Q1 2023 |
Income Statement
| Q1 2022 | Q2 2022 | Q3 2022 | Q1 2023 | |
|---|---|---|---|---|
| Revenue | $0 | $-1000 | $2000 | $16000 |
| YoY Growth | N/A | N/A | N/A | N/A |
Balance Sheet
| Q1 2022 | Q2 2022 | Q3 2022 | Q1 2023 | |
|---|---|---|---|---|
| Assets | $5.9M | $8.0M | $5.6M | $2.1M |
| Liabilities | $2.6M | $4.3M | $2.1M | $2.1M |
| Equity | $3.4M | $3.7M | $3.5M | $31000 |
Cash Flow
| Q1 2022 | Q2 2022 | Q3 2022 | Q1 2023 | |
|---|---|---|---|---|
| Operating CF | $-2.3M | $-1.6M | $-1.9M | $-2.1M |